Name: Tevogen Bio Holdings Inc. (TVGN) Cash Flow Statement
Creator: FinSpry

Tevogen Bio Holdings Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Tevogen Bio Holdings Inc. (TVGN) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Operating Activities
Net Income	-13.73	-60.48	-22.04	-15.60
Depreciation & Amortization	0.40	0.38	0.23	0.01
Stock Based Compensation	40.76	0.00	4.58	0.58
Change in Working Capital	-0.01	0.29	0.26	-1.25
Change in Accounts Payable	1.69	1.11	0.35	-1.09
Change in Other Working Capital	-1.69	51.64	-0.10	10.98
Other Operating Activities	-40.23	51.64	8.32	10.98
Net Cash from Operating Activities	-12.00	-8.17	-8.66	-5.27
Investing Activities
Capital Expenditures	0.00	-0.13	-0.48	-0.11
Net Cash from Investing Activities	0.00	-0.13	-0.48	-0.11
Financing Activities
Debt Repayment	1.00	0.00	0.00	0.00
Common Stock Repurchased	0.00	-342.98	0.00	0.00
Other Financing Activities	0.23	-0.13	0.00	0.00
Net Cash from Financing Activities	12.23	3.87	7.50	12.50
Summary
Net Change in Cash	0.23	-4.43	-1.63	7.12
Cash at Beginning of Period	1.05	5.48	0.34	0.00
Cash at End of Period	1.28	1.05	0.13	7.12
Free Cash Flow	-12.00	-8.30	-9.13	-5.38